Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$17,830
in 3 filings, $18K under 10b5-1 plans

Net −$17,830. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$12K Director sold 8% of stake
  2. Newton Charles W. −$6K Director sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2020-04-13 Arkin Bio Ventures Limited Partnership 10% owner Conversion +1,382,295 1,382,295
2020-04-13 Arkin Bio Ventures Limited Partnership 10% owner Conversion +343,270 1,725,565
2020-04-13 Arkin Bio Ventures Limited Partnership 10% owner Conversion +167,537 1,893,102
2020-04-13 Arkin Bio Ventures Limited Partnership 10% owner Purchase +120,000 $16.00 $1.9M 2,013,102
2020-04-13 Arkin Bio Ventures Limited Partnership 10% owner Conversion · Series A Preferred Stock −1,382,295 0
2020-04-13 Arkin Bio Ventures Limited Partnership 10% owner Conversion · Series B-1 Preferred Stock −343,270 0
2020-04-13 Arkin Bio Ventures Limited Partnership 10% owner Conversion · Series C Preferred Stock −167,537 0

Page 1 of 1 · 7 trades